Lincoln Pharmaceuticals

Lincoln Pharmaceuticals has reported a robust financial performance for the first quarter of FY2025, recording a 17% year-over-year increase in net profit to Rs. 28 crore. The Ahmedabad-based pharmaceutical company also witnessed a steady rise in revenue, supported by strong domestic demand and growing exports. With a continued focus on operational efficiency, international market expansion, and product innovation, the company has laid out a clear roadmap for sustained profitability.

Lincoln Pharmaceuticals is steering into a new era of strategic growth, with a sharp focus on lifestyle and chronic care—particularly in women's health and dermatology. The Ahmedabad-based drugmaker reported a net profit of Rs. 11.62 crore for the March quarter of FY25, down from Rs. 18.8 crore in the same period last year, despite a year-over-year increase in revenue. The company aims to bolster its global footprint through product registrations for exports while maintaining a net debt-free status. A long-term goal to reach Rs.